JP Morgan Chase’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.4M Hold
115,500
﹤0.01% 3249
2025
Q4
$5.6M Hold
115,500
﹤0.01% 3204
2025
Q3
$5.45M Buy
+115,500
New +$5.57M ﹤0.01% 3273
2025
Q2
Sell
-15,600
Closed -$865K 7600
2025
Q1
$865K Buy
+15,600
New +$844K ﹤0.01% 4449
2019
Q3
Sell
-152,200
Closed -$6.56M 5939
2019
Q2
$6.56M Buy
152,200
+60,000
+65% +$2.55M ﹤0.01% 2430
2019
Q1
$4.08M Buy
+92,200
New +$3.95M ﹤0.01% 2752
2017
Q4
Sell
-40,000
Closed -$1.98M 5568
2017
Q3
$1.98M Buy
+40,000
New +$1.94M ﹤0.01% 3164
2017
Q2
Sell
-143,700
Closed -$6.5M 5201
2017
Q1
$6.5M Buy
+143,700
New +$6.1M ﹤0.01% 2250

Other funds holding SNY

JP Morgan Chase's SNY Position: Q1 2026 in Review

JP Morgan Chase increased its Sanofi (SNY) stake by 86% in Q1 2026, buying an estimated $121M and bringing the position to 5,600,731 shares worth $262M. The position accounts for 0.02% of the portfolio, ranked #592.

JP Morgan Chase first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • JP Morgan Chase held 5,600,731 shares of Sanofi worth $262M as of Q1 2026.
  • JP Morgan Chase bought 2,589,773 Sanofi shares in Q1 2026, an estimated $121M.
  • Sanofi made up 0.02% of JP Morgan Chase's portfolio in Q1 2026, its #592 holding.
  • JP Morgan Chase first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.